- Home
- USEG vs ATYR Comparison
USEG vs ATYR Comparison
Compare USEG & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | USEG | ATYR |
|---|---|---|
| Founded | 1966 | 2005 |
| Country | United States | United States |
| Employees | N/A | 58 |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.5M | 50.9M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | USEG | ATYR |
|---|---|---|
| Price | $1.01 | $0.54 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 9 |
| Target Price | $3.50 | ★ $3.67 |
| AVG Volume (30 Days) | 1.7M | ★ 3.8M |
| Earning Date | 05-07-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.21 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $32,379,000.00 | N/A |
| Revenue This Year | $114,854.51 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.66 | $0.40 |
| 52 Week High | $2.75 | $7.29 |
Technical Indicators
Market Signals| Indicator | USEG | ATYR |
|---|---|---|
| Relative Strength Index (RSI) | 56.25 | 42.13 |
| Support Level | $0.94 | $0.40 |
| Resistance Level | $1.08 | $0.86 |
| Average True Range (ATR) | 0.05 | 0.08 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 85.80 | 23.67 |
Price Performance
Historical ComparisonAbout USEG U.S. Energy Corp. (DE)
US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.
About ATYR aTyr Pharma Inc.
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).